HRP930235B1 - ((benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines - Google Patents

((benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Info

Publication number
HRP930235B1
HRP930235B1 HR07/842,560A HRP930235A HRP930235B1 HR P930235 B1 HRP930235 B1 HR P930235B1 HR P930235 A HRP930235 A HR P930235A HR P930235 B1 HRP930235 B1 HR P930235B1
Authority
HR
Croatia
Prior art keywords
benzodioxan
benzopyran
benzofuran
alkylamino
alkyl substituted
Prior art date
Application number
HR07/842,560A
Other languages
English (en)
Inventor
Walter Jacobus Joseph Janssens
Original Assignee
Walter Jacobus Joseph Janssens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter Jacobus Joseph Janssens filed Critical Walter Jacobus Joseph Janssens
Publication of HRP930235A2 publication Critical patent/HRP930235A2/hr
Publication of HRP930235B1 publication Critical patent/HRP930235B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
HR07/842,560A 1992-02-27 1993-02-25 ((benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines HRP930235B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84256092A 1992-02-27 1992-02-27

Publications (2)

Publication Number Publication Date
HRP930235A2 HRP930235A2 (en) 1997-10-31
HRP930235B1 true HRP930235B1 (en) 1999-04-30

Family

ID=25287639

Family Applications (1)

Application Number Title Priority Date Filing Date
HR07/842,560A HRP930235B1 (en) 1992-02-27 1993-02-25 ((benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Country Status (37)

Country Link
US (4) US5541180A (lt)
EP (1) EP0639192B1 (lt)
JP (1) JP2779268B2 (lt)
KR (1) KR100190300B1 (lt)
CN (1) CN1038032C (lt)
AP (1) AP416A (lt)
AT (1) ATE138064T1 (lt)
AU (1) AU664237B2 (lt)
BG (1) BG62052B1 (lt)
CA (1) CA2117483C (lt)
CZ (1) CZ282092B6 (lt)
DE (1) DE69302687T2 (lt)
DK (1) DK0639192T3 (lt)
EE (1) EE03029B1 (lt)
ES (1) ES2087721T3 (lt)
FI (1) FI109122B (lt)
GR (1) GR3019927T3 (lt)
HR (1) HRP930235B1 (lt)
HU (2) HU222495B1 (lt)
IL (1) IL104868A (lt)
LT (1) LT3049B (lt)
LV (1) LV10715B (lt)
MX (1) MX9301053A (lt)
MY (1) MY110627A (lt)
NO (1) NO306255B1 (lt)
NZ (1) NZ249124A (lt)
OA (1) OA10095A (lt)
PH (1) PH31295A (lt)
PL (1) PL174736B1 (lt)
RO (1) RO115630B1 (lt)
RU (1) RU2121999C1 (lt)
SG (1) SG47763A1 (lt)
SI (1) SI9300097B (lt)
SK (1) SK280166B6 (lt)
TW (1) TW225531B (lt)
WO (1) WO1993017017A1 (lt)
ZA (1) ZA931404B (lt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286645B6 (cs) * 1993-08-19 2000-05-17 Janssen Pharmaceutica N.V. Substituované dihydropyranopyridiny jako takové a pro použití v lékařství, způsob a meziprodukty pro jejich výrobu, farmaceutické prostředky na jejich bázi a způsob jejich výroby
ATE256130T1 (de) * 1993-08-19 2003-12-15 Janssen Pharmaceutica Nv Gefässverengende dihydrobenzopyranderivate
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
WO1996041632A1 (en) * 1995-06-08 1996-12-27 Janssen Pharmaceutica N.V. Starch microsphere anti migraine composition
FR2752735B1 (fr) * 1996-09-05 1998-10-02 Synthelabo Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
EE04780B1 (et) * 1999-06-02 2007-02-15 Janssen Pharmaceutica N.V. Aminoalküül-asendatud bensodioksaani, bensofuraani või bensopüraani derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
IL146824A0 (en) 1999-06-02 2002-07-25 Janssen Pharmaceutica Nv Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
WO2002044159A2 (en) * 2000-11-29 2002-06-06 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
EP1379520B2 (en) * 2001-02-23 2014-04-09 Merck Sharp & Dohme Corp. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
HUP0402092A3 (en) 2001-07-26 2010-06-28 Merck Patent Gmbh Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions
RU2322443C2 (ru) * 2001-09-19 2008-04-20 Мерк Патент Гмбх Новое применение замещенных аминометилхроманов
KR20050092795A (ko) * 2003-01-31 2005-09-22 짐머 오르쏘바이올로직스 인코포레이티드 수핵 조직을 함유하는 하이드로젤 조성물
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
ZA200507112B (en) * 2003-03-31 2007-03-28 Taisho Pharmaceutical Co Ltd Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2007138485A2 (en) * 2006-01-18 2007-12-06 Evolva Sa Ppar modulators
CN105061392B (zh) * 2015-07-20 2017-07-18 上海现代哈森(商丘)药业有限公司 一种硫酸胍生合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636238A (lt) * 1962-08-20
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GR71865B (lt) * 1978-03-20 1983-07-07 Ciba Geigy
US4405922A (en) * 1979-05-23 1983-09-20 Hitachi Koki Company, Limited Failure detection circuit for impact printers or the like
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
CA2011899A1 (en) * 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
WO1994017017A1 (en) * 1991-07-15 1994-08-04 Exxon Research And Engineering Company Benzene removal from gasoline boiling range streams
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Also Published As

Publication number Publication date
FI109122B (fi) 2002-05-31
LV10715A (lv) 1995-06-20
CS202094A3 (en) 1995-01-18
HU9402464D0 (en) 1994-10-28
AP9300493A0 (en) 1993-04-30
LT3049B (en) 1994-10-25
SK102994A3 (en) 1995-07-11
NO943186L (no) 1994-08-29
PH31295A (en) 1998-07-06
FI943928A0 (fi) 1994-08-26
CA2117483A1 (en) 1993-09-02
MY110627A (en) 1998-09-30
RU94041210A (ru) 1996-07-10
US5607949A (en) 1997-03-04
AU3499193A (en) 1993-09-13
ATE138064T1 (de) 1996-06-15
BG62052B1 (bg) 1999-01-29
SI9300097B (en) 2001-12-31
HU222495B1 (hu) 2003-07-28
CN1079470A (zh) 1993-12-15
HU211742A9 (en) 1995-12-28
MX9301053A (es) 1994-03-31
PL174736B1 (pl) 1998-09-30
US5624952A (en) 1997-04-29
ZA931404B (en) 1994-08-26
NO943186D0 (no) 1994-08-29
IL104868A0 (en) 1993-06-10
FI943928A (fi) 1994-08-26
NZ249124A (en) 1995-08-28
DE69302687T2 (de) 1996-11-14
DE69302687D1 (de) 1996-06-20
WO1993017017A1 (en) 1993-09-02
LV10715B (en) 1995-12-20
SK280166B6 (sk) 1999-09-10
US5541180A (en) 1996-07-30
KR100190300B1 (ko) 1999-06-01
LTIP367A (lt) 1994-04-25
NO306255B1 (no) 1999-10-11
HRP930235A2 (en) 1997-10-31
BG98870A (bg) 1995-03-31
SG47763A1 (en) 1998-04-17
OA10095A (en) 1996-12-18
GR3019927T3 (en) 1996-08-31
DK0639192T3 (da) 1996-08-19
JP2779268B2 (ja) 1998-07-23
AU664237B2 (en) 1995-11-09
CA2117483C (en) 2001-01-09
RU2121999C1 (ru) 1998-11-20
EP0639192B1 (en) 1996-05-15
AP416A (en) 1995-09-29
SI9300097A (en) 1993-09-30
CN1038032C (zh) 1998-04-15
CZ282092B6 (cs) 1997-05-14
JPH07504408A (ja) 1995-05-18
IL104868A (en) 1998-01-04
EP0639192A1 (en) 1995-02-22
TW225531B (lt) 1994-06-21
RO115630B1 (ro) 2000-04-28
US5688952A (en) 1997-11-18
ES2087721T3 (es) 1996-07-16
EE03029B1 (et) 1997-08-15
HUT71129A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
HRP930235B1 (en) ((benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
EP0434249A3 (en) Benzofuran derivatives
GR3035089T3 (en) Analogs of pth.
ZA946470B (en) Benzofuran derivatives
ZA926334B (en) Benzodioxane derivatives.
GR3036577T3 (en) Novel carbocyclic adenosine analogs useful as immunosuppressants.
ZW1187A1 (en) Insecticidal trifluromethyl alkane derivatives
AU6346790A (en) Inertial stabilizing system
ZA926549B (en) Novel benzopyran derivatives
AR243522A1 (es) Compuesto de benzofurano substituido por n-heterociclo,procedimiento para prepararlo,compuestos intermedios empleados,procedimiento para su preparacion y composicion herbicida.
IT9082518A0 (it) Attacco di sicurezza, particolarmente per sci
AU5872590A (en) 4-pyridone-substituted chromans or chromenes
ZA937633B (en) Benzofuran derivatives
EP0435322A3 (en) Benzofuran derivatives
GB8621036D0 (en) Laser & control system
IT8982600A0 (it) Attacco di sicurezza, particolarmente per sci
ZA923547B (en) Benzofuran derivatives
EP0420470A3 (en) Naphthopyran compounds
IE901319L (en) Antihypertensive benzopyrans
IT9082542A0 (it) Attacco di sicurezza,particolarmente per sci
GB9025068D0 (en) Lactone compounds
ZA925060B (en) Benzofuran derivatives.
GB9005538D0 (en) Novel antihypertensive benzopyran derivatives
ZA909638B (en) Benzofuran derivatives
IT9082541A0 (it) Attacco di sicurezza,particolarmente per sci

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120113

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20130226